HCPCS J codes: Drugs administered other than oral method

1,107 active HCPCS Level II codes beginning with J. All sections.

• J0120 — Injection, tetracycline, up to 250 mg
• J0121 — Injection, omadacycline, 1 mg
• J0122 — Injection, eravacycline, 1 mg
• J0129 — Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J0130 — Injection abciximab, 10 mg
• J0131 — Injection, acetaminophen, not otherwise specified,10 mg
• J0132 — Injection, acetylcysteine, 100 mg
• J0133 — Injection, acyclovir, 5 mg
• J0134 — Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg
• J0136 — Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg
• J0137 — Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
• J0138 — Injection, acetaminophen 10 mg and ibuprofen 3 mg
• J0139 — Injection, adalimumab, 1 mg
• J0153 — Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
• J0163 — Injection, epinephrine in sodium chloride (endo), 0.1 mg
• J0164 — Injection, epinephrine in sodium chloride (baxter), 0.1 mg
• J0165 — Injection, epinephrine, not otherwise specified, 0.1 mg
• J0166 — Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg
• J0167 — Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg
• J0168 — Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg
• J0169 — Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg
• J0172 — Injection, aducanumab-avwa, 2 mg
• J0174 — Injection, lecanemab-irmb, 1 mg
• J0175 — Injection, donanemab-azbt, 2 mg
• J0177 — Injection, aflibercept hd, 1 mg
• J0178 — Injection, aflibercept, 1 mg
• J0179 — Injection, brolucizumab-dbll, 1 mg
• J0180 — Injection, agalsidase beta, 1 mg
• J0184 — Injection, amisulpride, 1 mg
• J0185 — Injection, aprepitant, 1 mg
• J0190 — Injection, biperiden lactate, per 5 mg
• J0200 — Injection, alatrofloxacin mesylate, 100 mg
• J0202 — Injection, alemtuzumab, 1 mg
• J0205 — Injection, alglucerase, per 10 units
• J0206 — Injection, allopurinol sodium, 1 mg
• J0207 — Injection, amifostine, 500 mg
• J0208 — Injection, sodium thiosulfate (pedmark), 100 mg
• J0209 — Injection, sodium thiosulfate (hope), 100 mg
• J0210 — Injection, methyldopate hcl, up to 250 mg
• J0211 — Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
• J0215 — Injection, alefacept, 0.5 mg
• J0216 — Injection, alfentanil hydrochloride, 500 micrograms
• J0217 — Injection, velmanase alfa-tycv, 1 mg
• J0218 — Injection, olipudase alfa-rpcp, 1 mg
• J0219 — Injection, avalglucosidase alfa-ngpt, 4 mg
• J0220 — Injection, alglucosidase alfa, 10 mg, not otherwise specified
• J0221 — Injection, alglucosidase alfa, (lumizyme), 10 mg
• J0222 — Injection, patisiran, 0.1 mg
• J0223 — Injection, givosiran, 0.5 mg
• J0224 — Injection, lumasiran, 0.5 mg
• J0225 — Injection, vutrisiran, 1 mg
• J0248 — Injection, remdesivir, 1 mg
• J0256 — Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg
• J0257 — Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg
• J0270 — Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J0275 — Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J0278 — Injection, amikacin sulfate, 100 mg
• J0280 — Injection, aminophyllin, up to 250 mg
• J0281 — Injection, aminocaproic acid, 1 gram
• J0282 — Injection, amiodarone hydrochloride, 30 mg
• J0283 — Injection, amiodarone hydrochloride (nexterone), 30 mg
• J0285 — Injection, amphotericin b, 50 mg
• J0287 — Injection, amphotericin b lipid complex, 10 mg
• J0288 — Injection, amphotericin b cholesteryl sulfate complex, 10 mg
• J0289 — Injection, amphotericin b liposome, 10 mg
• J0290 — Injection, ampicillin sodium, 500 mg
• J0291 — Injection, plazomicin, 5 mg
• J0295 — Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm
• J0300 — Injection, amobarbital, up to 125 mg
• J0330 — Injection, succinylcholine chloride, up to 20 mg
• J0348 — Injection, anidulafungin, 1 mg
• J0349 — Injection, rezafungin, 1 mg
• J0350 — Injection, anistreplase, per 30 units
• J0360 — Injection, hydralazine hcl, up to 20 mg
• J0364 — Injection, apomorphine hydrochloride, 1 mg
• J0365 — Injection, aprotonin, 10,000 kiu
• J0380 — Injection, metaraminol bitartrate, per 10 mg
• J0390 — Injection, chloroquine hydrochloride, up to 250 mg
• J0391 — Injection, artesunate, 1 mg
• J0395 — Injection, arbutamine hcl, 1 mg
• J0400 — Injection, aripiprazole, intramuscular, 0.25 mg
• J0401 — Injection, aripiprazole (abilify maintena), 1 mg
• J0402 — Injection, aripiprazole (abilify asimtufii), 1 mg
• J0456 — Injection, azithromycin, 500 mg
• J0457 — Injection, aztreonam, 100 mg
• J0458 — Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)
• J0461 — Injection, atropine sulfate, 0.01 mg
• J0462 — Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg
• J0470 — Injection, dimercaprol, per 100 mg
• J0475 — Injection, baclofen, 10 mg
• J0476 — Injection, baclofen, 50 mcg for intrathecal trial
• J0480 — Injection, basiliximab, 20 mg
• J0485 — Injection, belatacept, 1 mg
• J0490 — Injection, belimumab, 10 mg
• J0491 — Injection, anifrolumab-fnia, 1 mg
• J0500 — Injection, dicyclomine hcl, up to 20 mg
• J0515 — Injection, benztropine mesylate, per 1 mg
• J0517 — Injection, benralizumab, 1 mg
• J0520 — Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg
• J0525 — Injection, cefotetan disodium, 10 mg
• J0558 — Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
• J0561 — Injection, penicillin g benzathine, 100,000 units
• J0565 — Injection, bezlotoxumab, 10 mg
• J0567 — Injection, cerliponase alfa, 1 mg
• J0570 — Buprenorphine implant, 74.2 mg
• J0571 — Buprenorphine, oral, 1 mg
• J0572 — Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
• J0573 — Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
• J0574 — Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
• J0575 — Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
• J0577 — Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
• J0578 — Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
• J0582 — Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg
• J0583 — Injection, bivalirudin, 1 mg
• J0584 — Injection, burosumab-twza 1 mg
• J0585 — Injection, onabotulinumtoxina, 1 unit
• J0586 — Injection, abobotulinumtoxina, 5 units
• J0587 — Injection, rimabotulinumtoxinb, 100 units
• J0588 — Injection, incobotulinumtoxin a, 1 unit
• J0589 — Injection, daxibotulinumtoxina-lanm, 1 unit
• J0591 — Injection, deoxycholic acid, 1 mg
• J0592 — Injection, buprenorphine hydrochloride, 0.1 mg
• J0593 — Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
• J0594 — injection, busulfan, 1 mg
• J0595 — Injection, butorphanol tartrate, 1 mg
• J0596 — Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units
• J0597 — Injection, c-1 esterase inhibitor (human), berinert, 10 units
• J0598 — Injection, c-1 esterase inhibitor (human), cinryze, 10 units
• J0599 — Injection, c-1 esterase inhibitor (human), (haegarda), 10 units
• J0600 — Injection, edetate calcium disodium, up to 1000 mg
• J0601 — Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
• J0602 — Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)
• J0603 — Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
• J0604 — Cinacalcet, oral, 1 mg, (for esrd on dialysis)
• J0605 — Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)
• J0606 — Injection, etelcalcetide, 0.1 mg
• J0607 — Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)
• J0608 — Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)
• J0609 — Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)
• J0612 — Injection, calcium gluconate, not otherwise specified, 10 mg
• J0613 — Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg
• J0614 — Injection, treosulfan, 50 mg
• J0615 — Calcium acetate, oral, 23 mg (for esrd on dialysis)
• J0616 — Injection, metoprolol tartrate, 1 mg
• J0618 — Injection, calcium chloride, 2 mg
• J0620 — Injection, calcium glycerophosphate and calcium lactate, per 10 ml
• J0630 — Injection, calcitonin salmon, up to 400 units
• J0636 — Injection, calcitriol, 0.1 mcg
• J0637 — Injection, caspofungin acetate, 5 mg
• J0638 — Injection, canakinumab, 1 mg
• J0640 — Injection, leucovorin calcium, per 50 mg
• J0641 — Injection, levoleucovorin, not otherwise specified, 0.5 mg
• J0642 — Injection, levoleucovorin (khapzory), 0.5 mg
• J0650 — Injection, levothyroxine sodium, not otherwise specified, 10 mcg
• J0651 — Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg
• J0652 — Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
• J0665 — Injection, bupivicaine, not otherwise specified, 0.5 mg
• J0666 — Injection, bupivacaine liposome, 1 mg
• J0668 — Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
• J0670 — Injection, mepivacaine hydrochloride, per 10 ml
• J0675 — Injection, carboprost tromethamine, 0.1 mg
• J0681 — Injection, ceftobiprole medocaril sodium, 3 mg
• J0687 — Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg
• J0688 — Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg
• J0689 — Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
• J0690 — Injection, cefazolin sodium, 500 mg
• J0691 — Injection, lefamulin, 1 mg
• J0692 — Injection, cefepime hydrochloride, 500 mg
• J0694 — Injection, cefoxitin sodium, 1 gm
• J0695 — Injection, ceftolozane 50 mg and tazobactam 25 mg
• J0696 — Injection, ceftriaxone sodium, per 250 mg
• J0697 — Injection, sterile cefuroxime sodium, per 750 mg
• J0698 — Injection, cefotaxime sodium, per gm
• J0699 — Injection, cefiderocol, 10 mg
• J0701 — Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
• J0702 — Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
• J0703 — Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
• J0706 — Injection, caffeine citrate, 5 mg
• J0710 — Injection, cephapirin sodium, up to 1 gm
• J0712 — Injection, ceftaroline fosamil, 10 mg
• J0713 — Injection, ceftazidime, per 500 mg
• J0714 — Injection, ceftazidime and avibactam, 0.5 g/0.125 g
• J0715 — Injection, ceftizoxime sodium, per 500 mg
• J0716 — Injection, centruroides immune f(ab)2, up to 120 milligrams
• J0717 — Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J0720 — Injection, chloramphenicol sodium succinate, up to 1 gm
• J0725 — Injection, chorionic gonadotropin, per 1,000 usp units
• J0735 — Injection, clonidine hydrochloride, 1 mg
• J0736 — Injection, clindamycin phosphate, 300 mg
• J0737 — Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
• J0738 — Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
• J0739 — Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
• J0740 — Injection, cidofovir, 375 mg
• J0741 — Injection, cabotegravir and rilpivirine, 2mg/3mg
• J0742 — Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
• J0743 — Injection, cilastatin sodium; imipenem, per 250 mg
• J0744 — Injection, ciprofloxacin for intravenous infusion, 200 mg
• J0745 — Injection, codeine phosphate, per 30 mg
• J0750 — Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
• J0751 — Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
• J0752 — Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
• J0759 — Injection, clevidipine butyrate, 1 mg
• J0770 — Injection, colistimethate sodium, up to 150 mg
• J0775 — Injection, collagenase, clostridium histolyticum, 0.01 mg
• J0780 — Injection, prochlorperazine, up to 10 mg
• J0791 — Injection, crizanlizumab-tmca, 5 mg
• J0795 — Injection, corticorelin ovine triflutate, 1 microgram
• J0799 — Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified
• J0801 — Injection, corticotropin (acthar gel), up to 40 units
• J0802 — Injection, corticotropin (ani), up to 40 units
• J0834 — Injection, cosyntropin, 0.25 mg
• J0840 — Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
• J0841 — Injection, crotalidae immune f(ab')2 (equine), 120 mg
• J0850 — Injection, cytomegalovirus immune globulin intravenous (human), per vial
• J0870 — Injection, imetelstat, 1 mg
• J0872 — Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
• J0873 — Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
• J0874 — Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg
• J0875 — Injection, dalbavancin, 5 mg
• J0877 — Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg
• J0878 — Injection, daptomycin, 1 mg
• J0879 — Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)
• J0881 — Injection, darbepoetin alfa, 1 microgram (non-esrd use)
• J0882 — Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)
• J0883 — Injection, argatroban, 1 mg (for non-esrd use)
• J0884 — Injection, argatroban, 1 mg (for esrd on dialysis)
• J0885 — Injection, epoetin alfa, (for non-esrd use), 1000 units
• J0887 — Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
• J0888 — Injection, epoetin beta, 1 microgram, (for non esrd use)
• J0889 — Daprodustat, oral, 1 mg, (for esrd on dialysis)
• J0890 — Injection, peginesatide, 0.1 mg (for esrd on dialysis)
• J0891 — Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
• J0892 — Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
• J0893 — Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
• J0894 — Injection, decitabine, 1 mg
• J0895 — Injection, deferoxamine mesylate, 500 mg
• J0896 — Injection, luspatercept-aamt, 0.25 mg
• J0897 — Injection, denosumab, 1 mg
• J0898 — Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
• J0899 — Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
• J0901 — Vadadustat, oral, 1 mg (for esrd on dialysis)
• J0911 — Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)
• J0945 — Injection, brompheniramine maleate, per 10 mg
• J1000 — Injection, depo-estradiol cypionate, up to 5 mg
• J1010 — Injection, methylprednisolone acetate, 1 mg
• J1050 — Injection, medroxyprogesterone acetate, 1 mg
• J1071 — Injection, testosterone cypionate, 1 mg
• J1072 — Injection, testosterone cypionate (azmiro), 1 mg
• J1095 — Injection, dexamethasone 9 percent, intraocular, 1 microgram
• J1096 — Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
• J1097 — Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml
• J1100 — Injection, dexamethasone sodium phosphate, 1 mg
• J1105 — Dexmedetomidine, oral, 1 mcg
• J1110 — Injection, dihydroergotamine mesylate, per 1 mg
• J1120 — Injection, acetazolamide sodium, up to 500 mg
• J1130 — Injection, diclofenac sodium, 0.5 mg
• J1160 — Injection, digoxin, up to 0.5 mg
• J1162 — Injection, digoxin immune fab (ovine), per vial
• J1163 — Injection, diltiazem hydrochloride, 0.5 mg
• J1165 — Injection, phenytoin sodium, per 50 mg
• J1171 — Injection, hydromorphone, 0.1 mg
• J1180 — Injection, dyphylline, up to 500 mg
• J1190 — Injection, dexrazoxane hydrochloride, per 250 mg
• J1200 — Injection, diphenhydramine hcl, up to 50 mg
• J1201 — Injection, cetirizine hydrochloride, 0.5 mg
• J1202 — Miglustat, oral, 65 mg
• J1203 — Injection, cipaglucosidase alfa-atga, 5 mg
• J1205 — Injection, chlorothiazide sodium, per 500 mg
• J1212 — Injection, dmso, dimethyl sulfoxide, 50%, 50 ml
• J1230 — Injection, methadone hcl, up to 10 mg
• J1240 — Injection, dimenhydrinate, up to 50 mg
• J1245 — Injection, dipyridamole, per 10 mg
• J1250 — Injection, dobutamine hydrochloride, per 250 mg
• J1260 — Injection, dolasetron mesylate, 10 mg
• J1265 — Injection, dopamine hcl, 40 mg
• J1267 — Injection, doripenem, 10 mg
• J1270 — Injection, doxercalciferol, 1 mcg
• J1271 — Injection, doxycycline hyclate, 1 mg
• J1290 — Injection, ecallantide, 1 mg
• J1299 — Injection, eculizumab, 2 mg
• J1301 — Injection, edaravone, 1 mg
• J1302 — Injection, sutimlimab-jome, 10 mg
• J1303 — Injection, ravulizumab-cwvz, 10 mg
• J1304 — Injection, tofersen, 1 mg
• J1305 — Injection, evinacumab-dgnb, 5mg
• J1306 — Injection, inclisiran, 1 mg
• J1307 — Injection, crovalimab-akkz, 10 mg
• J1308 — Injection, famotidine, 0.25 mg
• J1320 — Injection, amitriptyline hcl, up to 20 mg
• J1322 — Injection, elosulfase alfa, 1 mg
• J1323 — Injection, elranatamab-bcmm, 1 mg
• J1324 — Injection, enfuvirtide, 1 mg
• J1325 — Injection, epoprostenol, 0.5 mg
• J1326 — Injection, zolbetuximab-clzb, 2 mg
• J1327 — Injection, eptifibatide, 5 mg
• J1330 — Injection, ergonovine maleate, up to 0.2 mg
• J1335 — Injection, ertapenem sodium, 500 mg
• J1364 — Injection, erythromycin lactobionate, per 500 mg
• J1370 — Injection, esomeprazole sodium, 1 mg
• J1380 — Injection, estradiol valerate, up to 10 mg
• J1410 — Injection, estrogen conjugated, per 25 mg
• J1411 — Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
• J1412 — Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes
• J1413 — Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
• J1414 — Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
• J1426 — Injection, casimersen, 10 mg
• J1427 — Injection, viltolarsen, 10 mg
• J1428 — Injection, eteplirsen, 10 mg
• J1429 — Injection, golodirsen, 10 mg
• J1430 — Injection, ethanolamine oleate, 100 mg
• J1434 — Injection, fosaprepitant (focinvez), 1 mg
• J1435 — Injection, estrone, per 1 mg
• J1436 — Injection, etidronate disodium, per 300 mg
• J1437 — Injection, ferric derisomaltose, 10 mg
• J1438 — Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J1439 — Injection, ferric carboxymaltose, 1 mg
• J1440 — Fecal microbiota, live - jslm, 1 ml
• J1442 — Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
• J1443 — Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron
• J1444 — Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron
• J1445 — Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron
• J1447 — Injection, tbo-filgrastim, 1 microgram
• J1448 — Injection, trilaciclib, 1mg
• J1449 — Injection, eflapegrastim-xnst, 0.1 mg
• J1450 — Injection fluconazole, 200 mg
• J1451 — Injection, fomepizole, 15 mg
• J1452 — Injection, fomivirsen sodium, intraocular, 1.65 mg
• J1453 — Injection, fosaprepitant, 1 mg
• J1454 — Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
• J1455 — Injection, foscarnet sodium, per 1000 mg
• J1456 — Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
• J1457 — Injection, gallium nitrate, 1 mg
• J1458 — Injection, galsulfase, 1 mg
• J1459 — Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
• J1460 — Injection, gamma globulin, intramuscular, 1 cc
• J1551 — Injection, immune globulin (cutaquig), 100 mg
• J1552 — Injection, immune globulin (alyglo), 500 mg
• J1554 — Injection, immune globulin (asceniv), 500 mg
• J1555 — Injection, immune globulin (cuvitru), 100 mg
• J1556 — Injection, immune globulin (bivigam), 500 mg
• J1557 — Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
• J1558 — Injection, immune globulin (xembify), 100 mg
• J1559 — Injection, immune globulin (hizentra), 100 mg
• J1560 — Injection, gamma globulin, intramuscular, over 10 cc
• J1561 — Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
• J1562 — Injection, immune globulin (vivaglobin), 100 mg
• J1566 — Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
• J1568 — Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
• J1569 — Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
• J1570 — Injection, ganciclovir sodium, 500 mg
• J1571 — Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
• J1572 — Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
• J1573 — Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
• J1574 — Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg
• J1575 — Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
• J1576 — Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
• J1580 — Injection, garamycin, gentamicin, up to 80 mg
• J1595 — Injection, glatiramer acetate, 20 mg
• J1596 — Injection, glycopyrrolate, 0.1 mg
• J1597 — Injection, glycopyrrolate (glyrx-pf), 0.1 mg
• J1598 — Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
• J1599 — Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
• J1600 — Injection, gold sodium thiomalate, up to 50 mg
• J1602 — Injection, golimumab, 1 mg, for intravenous use
• J1610 — Injection, glucagon hydrochloride, per 1 mg
• J1611 — Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
• J1612 — Injection, glucagon (gvoke), 0.01 mg
• J1620 — Injection, gonadorelin hydrochloride, per 100 mcg
• J1626 — Injection, granisetron hydrochloride, 100 mcg
• J1627 — Injection, granisetron, extended-release, 0.1 mg
• J1628 — Injection, guselkumab, 1 mg
• J1630 — Injection, haloperidol, up to 5 mg
• J1631 — Injection, haloperidol decanoate, per 50 mg
• J1632 — Injection, brexanolone, 1 mg
• J1640 — Injection, hemin, 1 mg
• J1642 — Injection, heparin sodium, (heparin lock flush), per 10 units
• J1643 — Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units
• J1644 — Injection, heparin sodium, per 1000 units
• J1645 — Injection, dalteparin sodium, per 2500 iu
• J1650 — Injection, enoxaparin sodium, 10 mg
• J1652 — Injection, fondaparinux sodium, 0.5 mg
• J1655 — Injection, tinzaparin sodium, 1000 iu
• J1670 — Injection, tetanus immune globulin, human, up to 250 units
• J1675 — Injection, histrelin acetate, 10 micrograms
• J1700 — Injection, hydrocortisone acetate, up to 25 mg
• J1710 — Injection, hydrocortisone sodium phosphate, up to 50 mg
• J1720 — Injection, hydrocortisone sodium succinate, up to 100 mg
• J1726 — Injection, hydroxyprogesterone caproate, (makena), 10 mg
• J1729 — Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
• J1730 — Injection, diazoxide, up to 300 mg
• J1738 — Injection, meloxicam, 1 mg
• J1740 — Injection, ibandronate sodium, 1 mg
• J1741 — Injection, ibuprofen, 100 mg
• J1742 — Injection, ibutilide fumarate, 1 mg
• J1743 — Injection, idursulfase, 1 mg
• J1744 — Injection, icatibant, 1 mg
• J1745 — Injection, infliximab, excludes biosimilar, 10 mg
• J1746 — Injection, ibalizumab-uiyk, 10 mg
• J1747 — Injection, spesolimab-sbzo, 1 mg
• J1748 — Injection, infliximab-dyyb (zymfentra), 10 mg
• J1749 — Injection, iloprost, 0.1 mcg
• J1750 — Injection, iron dextran, 50 mg
• J1756 — Injection, iron sucrose, 1 mg
• J1786 — Injection, imiglucerase, 10 units
• J1790 — Injection, droperidol, up to 5 mg
• J1800 — Injection, propranolol hcl, up to 1 mg
• J1805 — Injection, esmolol hydrochloride, 10 mg
• J1806 — Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
• J1807 — Injection, ethacrynate sodium, 1 mg
• J1808 — Injection, folic acid, 0.1 mg
• J1809 — Injection, fosdenopterin, 0.1 mg
• J1811 — Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
• J1812 — Insulin (fiasp), per 5 units
• J1813 — Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
• J1814 — Insulin (lyumjev), per 5 units
• J1815 — Injection, insulin, per 5 units
• J1817 — Insulin for administration through dme (i.e., insulin pump) per 50 units
• J1823 — Injection, inebilizumab-cdon, 1 mg
• J1826 — Injection, interferon beta-1a, 30 mcg
• J1830 — Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J1833 — Injection, isavuconazonium, 1 mg
• J1834 — Injection, isoniazid, 1 mg
• J1835 — Injection, itraconazole, 50 mg
• J1836 — Injection, metronidazole, 10 mg
• J1885 — Injection, ketorolac tromethamine, per 15 mg
• J1920 — Injection, labetalol hydrochloride, 5 mg
• J1921 — Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
• J1930 — Injection, lanreotide, 1 mg
• J1931 — Injection, laronidase, 0.1 mg
• J1932 — Injection, lanreotide, (cipla), 1 mg
• J1938 — Injection, furosemide, 1 mg
• J1939 — Injection, bumetanide, 0.5 mg
• J1941 — Injection, furosemide (furoscix), 20 mg
• J1943 — Injection, aripiprazole lauroxil, (aristada initio), 1 mg
• J1944 — Injection, aripiprazole lauroxil, (aristada), 1 mg
• J1945 — Injection, lepirudin, 50 mg
• J1950 — Injection, leuprolide acetate (for depot suspension), per 3.75 mg
• J1951 — Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg
• J1952 — Leuprolide injectable, camcevi, 1 mg
• J1953 — Injection, levetiracetam, 10 mg
• J1954 — Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg
• J1955 — Injection, levocarnitine, per 1 gm
• J1956 — Injection, levofloxacin, 250 mg
• J1960 — Injection, levorphanol tartrate, up to 2 mg
• J1961 — Injection, lenacapavir (only for use as hiv treatment), 1 mg
• J1980 — Injection, hyoscyamine sulfate, up to 0.25 mg
• J1990 — Injection, chlordiazepoxide hcl, up to 100 mg
• J2002 — Injection, lidocaine hcl in 5% dextrose, 1 mg
• J2003 — Injection, lidocaine hydrochloride, 1 mg
• J2004 — Injection, lidocaine hcl with epinephrine, 1 mg
• J2010 — Injection, lincomycin hcl, up to 300 mg
• J2020 — Injection, linezolid, 200 mg
• J2021 — Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
• J2060 — Injection, lorazepam, 2 mg
• J2062 — Loxapine for inhalation, 1 mg
• J2151 — Injection, mannitol, 250 mg
• J2170 — Injection, mecasermin, 1 mg
• J2175 — Injection, meperidine hydrochloride, per 100 mg
• J2180 — Injection, meperidine and promethazine hcl, up to 50 mg
• J2182 — Injection, mepolizumab, 1 mg
• J2183 — Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg
• J2184 — Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg
• J2185 — Injection, meropenem, 100 mg
• J2186 — Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
• J2210 — Injection, methylergonovine maleate, up to 0.2 mg
• J2212 — Injection, methylnaltrexone, 0.1 mg
• J2246 — Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg
• J2247 — Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg
• J2248 — Injection, micafungin sodium, 1 mg
• J2249 — Injection, remimazolam, 1 mg
• J2250 — Injection, midazolam hydrochloride, per 1 mg
• J2251 — Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
• J2252 — Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
• J2253 — Injection, midazolam (seizalam), 1 mg
• J2260 — Injection, milrinone lactate, 5 mg
• J2265 — Injection, minocycline hydrochloride, 1 mg
• J2267 — Injection, mirikizumab-mrkz, 1 mg
• J2270 — Injection, morphine sulfate, up to 10 mg
• J2272 — Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg
• J2274 — Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
• J2277 — Injection, motixafortide, 0.25 mg
• J2278 — Injection, ziconotide, 1 microgram
• J2280 — Injection, moxifloxacin, 100 mg
• J2281 — Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg
• J2290 — Injection, nafcillin sodium, 20 mg
• J2291 — Injection, nafcillin sodium (baxter), 20 mg
• J2300 — Injection, nalbuphine hydrochloride, per 10 mg
• J2305 — Injection, nitroglycerin, 5 mg
• J2312 — Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg
• J2313 — Injection, naloxone hydrochloride (zimhi), 0.01 mg
• J2315 — Injection, naltrexone, depot form, 1 mg
• J2320 — Injection, nandrolone decanoate, up to 50 mg
• J2323 — Injection, natalizumab, 1 mg
• J2325 — Injection, nesiritide, 0.1 mg
• J2326 — Injection, nusinersen, 0.1 mg
• J2327 — Injection, risankizumab-rzaa, intravenous, 1 mg
• J2329 — Injection, ublituximab-xiiy, 1mg
• J2350 — Injection, ocrelizumab, 1 mg
• J2351 — Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq
• J2353 — Injection, octreotide, depot form for intramuscular injection, 1 mg
• J2354 — Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
• J2355 — Injection, oprelvekin, 5 mg
• J2356 — Injection, tezepelumab-ekko, 1 mg
• J2357 — Injection, omalizumab, 5 mg
• J2358 — Injection, olanzapine, long-acting, 1 mg
• J2359 — Injection, olanzapine, 0.5 mg
• J2360 — Injection, orphenadrine citrate, up to 60 mg
• J2371 — Injection, phenylephrine hydrochloride, 20 micrograms
• J2372 — Injection, phenylephrine hydrochloride (biorphen), 20 micrograms
• J2373 — Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms
• J2401 — Injection, chloroprocaine hydrochloride, per 1 mg
• J2402 — Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
• J2403 — Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
• J2404 — Injection, nicardipine, 0.1 mg
• J2405 — Injection, ondansetron hydrochloride, per 1 mg
• J2406 — Injection, oritavancin (kimyrsa), 10 mg
• J2407 — Injection, oritavancin (orbactiv), 10 mg
• J2410 — Injection, oxymorphone hcl, up to 1 mg
• J2425 — Injection, palifermin, 50 micrograms
• J2426 — Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
• J2427 — Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
• J2428 — Injection, paliperidone palmitate extended release (erzofri), 1 mg
• J2430 — Injection, pamidronate disodium, per 30 mg
• J2440 — Injection, papaverine hcl, up to 60 mg
• J2460 — Injection, oxytetracycline hcl, up to 50 mg
• J2468 — Injection, palonosetron hydrochloride (posfrea), 25 micrograms
• J2469 — Injection, palonosetron hcl, 25 mcg
• J2470 — Injection, pantoprazole sodium, 40 mg
• J2471 — Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg
• J2472 — Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg
• J2501 — Injection, paricalcitol, 1 mcg
• J2502 — Injection, pasireotide long acting, 1 mg
• J2504 — Injection, pegademase bovine, 25 iu
• J2506 — Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
• J2507 — Injection, pegloticase, 1 mg
• J2508 — Injection, pegunigalsidase alfa-iwxj, 1 mg
• J2510 — Injection, penicillin g procaine, aqueous, up to 600,000 units
• J2513 — Injection, pentastarch, 10% solution, 100 ml
• J2515 — Injection, pentobarbital sodium, per 50 mg
• J2540 — Injection, penicillin g potassium, up to 600,000 units
• J2543 — Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)
• J2545 — Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
• J2547 — Injection, peramivir, 1 mg
• J2550 — Injection, promethazine hcl, up to 50 mg
• J2560 — Injection, phenobarbital sodium, up to 120 mg
• J2561 — Injection, phenobarbital sodium (sezaby), 1 mg
• J2562 — Injection, plerixafor, 1 mg
• J2590 — Injection, oxytocin, up to 10 units
• J2597 — Injection, desmopressin acetate, per 1 mcg
• J2598 — Injection, vasopressin, 1 unit
• J2599 — Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit
• J2601 — Injection, vasopressin (baxter), 1 unit
• J2650 — Injection, prednisolone acetate, up to 1 ml
• J2670 — Injection, tolazoline hcl, up to 25 mg
• J2675 — Injection, progesterone, per 50 mg
• J2679 — Injection, fluphenazine hcl, 1.25 mg
• J2680 — Injection, fluphenazine decanoate, up to 25 mg
• J2690 — Injection, procainamide hcl, up to 1 gm
• J2700 — Injection, oxacillin sodium, up to 250 mg
• J2704 — Injection, propofol, 10 mg
• J2710 — Injection, neostigmine methylsulfate, up to 0.5 mg
• J2720 — Injection, protamine sulfate, per 10 mg
• J2724 — Injection, protein c concentrate, intravenous, human, 10 iu
• J2725 — Injection, protirelin, per 250 mcg
• J2730 — Injection, pralidoxime chloride, up to 1 gm
• J2760 — Injection, phentolamine mesylate, up to 5 mg
• J2765 — Injection, metoclopramide hcl, up to 10 mg
• J2770 — Injection, quinupristin/dalfopristin, 500 mg (150/350)
• J2777 — Injection, faricimab-svoa, 0.1 mg
• J2778 — Injection, ranibizumab, 0.1 mg
• J2779 — Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
• J2781 — Injection, pegcetacoplan, intravitreal, 1 mg
• J2782 — Injection, avacincaptad pegol, 0.1 mg
• J2783 — Injection, rasburicase, 0.5 mg
• J2785 — Injection, regadenoson, 0.1 mg
• J2786 — Injection, reslizumab, 1 mg
• J2787 — Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml
• J2788 — Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)
• J2790 — Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
• J2791 — Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu
• J2792 — Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu
• J2793 — Injection, rilonacept, 1 mg
• J2794 — Injection, risperidone (risperdal consta), 0.5 mg
• J2795 — Injection, ropivacaine hydrochloride, 1 mg
• J2797 — Injection, rolapitant, 0.5 mg
• J2798 — Injection, risperidone, (perseris), 0.5 mg
• J2799 — Injection, risperidone (uzedy), 1 mg
• J2800 — Injection, methocarbamol, up to 10 ml
• J2801 — Injection, risperidone (rykindo), 0.5 mg
• J2802 — Injection, romiplostim, 1 microgram
• J2804 — Injection, rifampin, 1 mg
• J2805 — Injection, sincalide, 5 micrograms
• J2810 — Injection, theophylline, per 40 mg
• J2820 — Injection, sargramostim (gm-csf), 50 mcg
• J2840 — Injection, sebelipase alfa, 1 mg
• J2850 — Injection, secretin, synthetic, human, 1 microgram
• J2860 — Injection, siltuximab, 10 mg
• J2865 — Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg
• J2910 — Injection, aurothioglucose, up to 50 mg
• J2916 — Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
• J2919 — Injection, methylprednisolone sodium succinate, 5 mg
• J2940 — Injection, somatrem, 1 mg
• J2941 — Injection, somatropin, 1 mg
• J2950 — Injection, promazine hcl, up to 25 mg
• J2993 — Injection, reteplase, 18.1 mg
• J2995 — Injection, streptokinase, per 250,000 iu
• J2997 — Injection, alteplase recombinant, 1 mg
• J2998 — Injection, plasminogen, human-tvmh, 1 mg
• J3000 — Injection, streptomycin, up to 1 gm
• J3010 — Injection, fentanyl citrate, 0.1 mg
• J3030 — Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J3031 — Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
• J3032 — Injection, eptinezumab-jjmr, 1 mg
• J3055 — Injection, talquetamab-tgvs, 0.25 mg
• J3060 — Injection, taliglucerase alfa, 10 units
• J3070 — Injection, pentazocine, 30 mg
• J3090 — Injection, tedizolid phosphate, 1 mg
• J3095 — Injection, telavancin, 10 mg
• J3101 — Injection, tenecteplase, 1 mg
• J3105 — Injection, terbutaline sulfate, up to 1 mg
• J3110 — Injection, teriparatide, 10 mcg
• J3111 — Injection, romosozumab-aqqg, 1 mg
• J3121 — Injection, testosterone enanthate, 1 mg
• J3145 — Injection, testosterone undecanoate, 1 mg
• J3230 — Injection, chlorpromazine hcl, up to 50 mg
• J3240 — Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
• J3241 — Injection, teprotumumab-trbw, 10 mg
• J3243 — Injection, tigecycline, 1 mg
• J3244 — Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
• J3245 — Injection, tildrakizumab, 1 mg
• J3246 — Injection, tirofiban hcl, 0.25 mg
• J3247 — Injection, secukinumab, intravenous, 1 mg
• J3250 — Injection, trimethobenzamide hcl, up to 200 mg
• J3260 — Injection, tobramycin sulfate, up to 80 mg
• J3262 — Injection, tocilizumab, 1 mg
• J3263 — Injection, toripalimab-tpzi, 1 mg
• J3265 — Injection, torsemide, 10 mg/ml
• J3280 — Injection, thiethylperazine maleate, up to 10 mg
• J3285 — Injection, treprostinil, 1 mg
• J3290 — Injection, tranexamic acid, 5 mg
• J3299 — Injection, triamcinolone acetonide (xipere), 1 mg
• J3300 — Injection, triamcinolone acetonide, preservative free, 1 mg
• J3301 — Injection, triamcinolone acetonide, not otherwise specified, 10 mg
• J3302 — Injection, triamcinolone diacetate, per 5 mg
• J3303 — Injection, triamcinolone hexacetonide, per 5 mg
• J3304 — Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
• J3305 — Injection, trimetrexate glucuronate, per 25 mg
• J3310 — Injection, perphenazine, up to 5 mg
• J3315 — Injection, triptorelin pamoate, 3.75 mg
• J3316 — Injection, triptorelin, extended-release, 3.75 mg
• J3320 — Injection, spectinomycin dihydrochloride, up to 2 gm
• J3350 — Injection, urea, up to 40 gm
• J3355 — Injection, urofollitropin, 75 iu
• J3357 — Ustekinumab, for subcutaneous injection, 1 mg
• J3358 — Ustekinumab, for intravenous injection, 1 mg
• J3360 — Injection, diazepam, up to 5 mg
• J3364 — Injection, urokinase, 5000 iu vial
• J3365 — Injection, iv, urokinase, 250,000 i.u. vial
• J3373 — Injection, vancomycin hydrochloride, 10 mg
• J3374 — Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg
• J3375 — Injection, vancomycin hydrochloride (xellia), not therapeutically equivalent to j3373, 10 mg
• J3380 — Injection, vedolizumab, intravenous, 1 mg
• J3385 — Injection, velaglucerase alfa, 100 units
• J3391 — Injection, atidarsagene autotemcel, per treatment
• J3392 — Injection, exagamglogene autotemcel, per treatment
• J3393 — Injection, betibeglogene autotemcel, per treatment
• J3394 — Injection, lovotibeglogene autotemcel, per treatment
• J3396 — Injection, verteporfin, 0.1 mg
• J3397 — Injection, vestronidase alfa-vjbk, 1 mg
• J3398 — Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
• J3399 — Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes
• J3400 — Injection, triflupromazine hcl, up to 20 mg
• J3401 — Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
• J3402 — Injection, remestemcel-l-rknd, per therapeutic dose
• J3403 — Revakinagene taroretcel-lwey, per implant
• J3410 — Injection, hydroxyzine hcl, up to 25 mg
• J3411 — Injection, thiamine hcl, 100 mg
• J3415 — Injection, pyridoxine hcl, 100 mg
• J3420 — Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
• J3424 — Injection, hydroxocobalamin, intravenous, 25 mg
• J3425 — Injection, hydroxocobalamin, intramuscular, 10 mcg
• J3430 — Injection, phytonadione (vitamin k), per 1 mg
• J3465 — Injection, voriconazole, 10 mg
• J3470 — Injection, hyaluronidase, up to 150 units
• J3471 — Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)
• J3472 — Injection, hyaluronidase, ovine, preservative free, per 1000 usp units
• J3473 — Injection, hyaluronidase, recombinant, 1 usp unit
• J3475 — Injection, magnesium sulfate, per 500 mg
• J3480 — Injection, potassium chloride, per 2 meq
• J3485 — Injection, zidovudine, 10 mg
• J3486 — Injection, ziprasidone mesylate, 10 mg
• J3489 — Injection, zoledronic acid, 1 mg
• J3490 — Unclassified drugs
• J3520 — Edetate disodium, per 150 mg
• J3530 — Nasal vaccine inhalation
• J3535 — Drug administered through a metered dose inhaler
• J3570 — Laetrile, amygdalin, vitamin b17
• J3590 — Unclassified biologics
• J3591 — Unclassified drug or biological used for esrd on dialysis
• J7030 — Infusion, normal saline solution , 1000 cc
• J7040 — Infusion, normal saline solution, sterile (500 ml = 1 unit)
• J7042 — 5% dextrose/normal saline (500 ml = 1 unit)
• J7050 — Infusion, normal saline solution, 250 cc
• J7060 — 5% dextrose/water (500 ml = 1 unit)
• J7070 — Infusion, d5w, 1000 cc
• J7100 — Infusion, dextran 40, 500 ml
• J7110 — Infusion, dextran 75, 500 ml
• J7120 — Ringers lactate infusion, up to 1000 cc
• J7121 — 5% dextrose in lactated ringers infusion, up to 1000 cc
• J7131 — Hypertonic saline solution, 1 ml
• J7165 — Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
• J7168 — Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
• J7169 — Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
• J7170 — Injection, emicizumab-kxwh, 0.5 mg
• J7171 — Injection, adamts13, recombinant-krhn, 10 iu
• J7172 — Injection, marstacimab-hncq, 0.5 mg
• J7173 — Injection, concizumab-mtci, 0.5 mg
• J7174 — Injection, fitusiran, 0.04 mg
• J7175 — Injection, factor x, (human), 1 i.u.
• J7177 — Injection, human fibrinogen concentrate (fibryga), 1 mg
• J7178 — Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
• J7179 — Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
• J7180 — Injection, factor xiii (antihemophilic factor, human), 1 i.u.
• J7181 — Injection, factor xiii a-subunit, (recombinant), per iu
• J7182 — Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu
• J7183 — Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco
• J7185 — Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.
• J7186 — Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.
• J7187 — Injection, von willebrand factor complex (humate-p), per iu vwf:rco
• J7188 — Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.
• J7189 — Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram
• J7190 — Factor viii (antihemophilic factor, human) per i.u.
• J7191 — Factor viii (antihemophilic factor (porcine)), per i.u.
• J7192 — Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified
• J7193 — Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.
• J7194 — Factor ix, complex, per i.u.
• J7195 — Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified
• J7196 — Injection, antithrombin recombinant, 50 i.u.
• J7197 — Antithrombin iii (human), per i.u.
• J7198 — Anti-inhibitor, per i.u.
• J7199 — Hemophilia clotting factor, not otherwise classified
• J7200 — Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu
• J7201 — Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.
• J7202 — Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.
• J7203 — Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
• J7204 — Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu
• J7205 — Injection, factor viii fc fusion protein (recombinant), per iu
• J7207 — Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
• J7208 — Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.
• J7209 — Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.
• J7210 — Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.
• J7211 — Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.
• J7212 — Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram
• J7213 — Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.
• J7214 — Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.
• J7294 — Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each
• J7295 — Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
• J7296 — Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg
• J7297 — Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg
• J7298 — Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg
• J7300 — Intrauterine copper contraceptive (paragard)
• J7301 — Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
• J7304 — Contraceptive supply, hormone containing patch, each
• J7306 — Levonorgestrel (contraceptive) implant system, including implants and supplies
• J7307 — Etonogestrel (contraceptive) implant system, including implant and supplies
• J7308 — Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
• J7309 — Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
• J7310 — Ganciclovir, 4.5 mg, long-acting implant
• J7311 — Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
• J7312 — Injection, dexamethasone, intravitreal implant, 0.1 mg
• J7313 — Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
• J7314 — Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
• J7315 — Mitomycin, ophthalmic, 0.2 mg
• J7316 — Injection, ocriplasmin, 0.125 mg
• J7318 — Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg
• J7320 — Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg
• J7321 — Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose
• J7322 — Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
• J7323 — Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose
• J7324 — Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose
• J7325 — Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg
• J7326 — Hyaluronan or derivative, gel-one, for intra-articular injection, per dose
• J7327 — Hyaluronan or derivative, monovisc, for intra-articular injection, per dose
• J7328 — Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg
• J7329 — Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg
• J7330 — Autologous cultured chondrocytes, implant
• J7331 — Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg
• J7332 — Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg
• J7336 — Capsaicin 8% patch, per square centimeter
• J7340 — Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml
• J7342 — Instillation, ciprofloxacin otic suspension, 6 mg
• J7345 — Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
• J7351 — Injection, bimatoprost, intracameral implant, 1 microgram
• J7352 — Afamelanotide implant, 1 mg
• J7353 — Anacaulase-bcdb, 8.8% gel, 1 gram
• J7354 — Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
• J7355 — Injection, travoprost, intracameral implant, 1 microgram
• J7356 — Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg
• J7402 — Mometasone furoate sinus implant, (sinuva), 10 micrograms
• J7500 — Azathioprine, oral, 50 mg
• J7501 — Azathioprine, parenteral, 100 mg
• J7502 — Cyclosporine, oral, 100 mg
• J7503 — Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
• J7504 — Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
• J7505 — Muromonab-cd3, parenteral, 5 mg
• J7507 — Tacrolimus, immediate release, oral, 1 mg
• J7508 — Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
• J7509 — Methylprednisolone oral, per 4 mg
• J7510 — Prednisolone oral, per 5 mg
• J7511 — Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
• J7512 — Prednisone, immediate release or delayed release, oral, 1 mg
• J7513 — Daclizumab, parenteral, 25 mg
• J7514 — Mycophenolate mofetil (myhibbin), oral suspension, 100 mg
• J7515 — Cyclosporine, oral, 25 mg
• J7516 — Injection, cyclosporine, 250 mg
• J7517 — Mycophenolate mofetil, oral, 250 mg
• J7518 — Mycophenolic acid, oral, 180 mg
• J7519 — Injection, mycophenolate mofetil, 10 mg
• J7520 — Sirolimus, oral, 1 mg
• J7521 — Tacrolimus, granules, oral suspension, 0.1 mg
• J7525 — Tacrolimus, parenteral, 5 mg
• J7527 — Everolimus, oral, 0.25 mg
• J7599 — Immunosuppressive drug, not otherwise classified
• J7601 — Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
• J7604 — Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
• J7605 — Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
• J7606 — Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
• J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
• J7608 — Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
• J7609 — Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
• J7610 — Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
• J7611 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
• J7612 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
• J7613 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
• J7614 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
• J7615 — Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
• J7620 — Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
• J7622 — Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7624 — Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7626 — Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
• J7627 — Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
• J7628 — Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7629 — Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7631 — Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
• J7632 — Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
• J7633 — Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
• J7634 — Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
• J7635 — Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7636 — Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7637 — Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7638 — Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7639 — Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
• J7640 — Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
• J7641 — Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
• J7642 — Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7643 — Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7644 — Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
• J7645 — Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7647 — Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7648 — Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
• J7649 — Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
• J7650 — Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7657 — Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7658 — Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
• J7659 — Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
• J7660 — Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7665 — Mannitol, administered through an inhaler, 5 mg
• J7667 — Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams
• J7668 — Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
• J7669 — Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
• J7670 — Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
• J7674 — Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
• J7676 — Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg
• J7677 — Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
• J7680 — Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7681 — Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7682 — Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
• J7683 — Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7684 — Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7685 — Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
• J7686 — Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
• J7699 — Noc drugs, inhalation solution administered through dme
• J7799 — Noc drugs, other than inhalation drugs, administered through dme
• J7999 — Compounded drug, not otherwise classified
• J8498 — Antiemetic drug, rectal/suppository, not otherwise specified
• J8499 — Prescription drug, oral, non chemotherapeutic, nos
• J8501 — Aprepitant, oral, 5 mg
• J8510 — Busulfan; oral, 2 mg
• J8515 — Cabergoline, oral, 0.25 mg
• J8522 — Capecitabine, oral, 50 mg
• J8530 — Cyclophosphamide; oral, 25 mg
• J8540 — Dexamethasone, oral, 0.25 mg
• J8541 — Dexamethasone (hemady), oral, 0.25 mg
• J8560 — Etoposide; oral, 50 mg
• J8562 — Fludarabine phosphate, oral, 10 mg
• J8565 — Gefitinib, oral, 250 mg
• J8597 — Antiemetic drug, oral, not otherwise specified
• J8600 — Melphalan; oral, 2 mg
• J8610 — Methotrexate; oral, 2.5 mg
• J8611 — Methotrexate (jylamvo), oral, 2.5 mg
• J8612 — Methotrexate (xatmep), oral, 2.5 mg
• J8650 — Nabilone, oral, 1 mg
• J8655 — Netupitant 300 mg and palonosetron 0.5 mg, oral
• J8670 — Rolapitant, oral, 1 mg
• J8700 — Temozolomide, oral, 5 mg
• J8705 — Topotecan, oral, 0.25 mg
• J8999 — Prescription drug, oral, chemotherapeutic, nos
• J9000 — Injection, doxorubicin hydrochloride, 10 mg
• J9011 — Injection, datopotamab deruxtecan-dlnk, 1 mg
• J9015 — Injection, aldesleukin, per single use vial
• J9017 — Injection, arsenic trioxide, 1 mg
• J9019 — Injection, asparaginase (erwinaze), 1,000 iu
• J9020 — Injection, asparaginase, not otherwise specified, 10,000 units
• J9021 — Injection, asparaginase, recombinant, (rylaze), 0.1 mg
• J9022 — Injection, atezolizumab, 10 mg
• J9023 — Injection, avelumab, 10 mg
• J9024 — Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
• J9025 — Injection, azacitidine, 1 mg
• J9026 — Injection, tarlatamab-dlle, 1 mg
• J9027 — Injection, clofarabine, 1 mg
• J9028 — Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
• J9029 — Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
• J9030 — Bcg live intravesical instillation, 1 mg
• J9032 — Injection, belinostat, 10 mg
• J9033 — Injection, bendamustine hydrochloride, 1 mg
• J9034 — Injection, bendamustine hcl (bendeka), 1 mg
• J9035 — Injection, bevacizumab, 10 mg
• J9036 — Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
• J9038 — Injection, axatilimab-csfr, 0.1 mg
• J9039 — Injection, blinatumomab, 1 microgram
• J9040 — Injection, bleomycin sulfate, 15 units
• J9041 — Injection, bortezomib, 0.1 mg
• J9042 — Injection, brentuximab vedotin, 1 mg
• J9043 — Injection, cabazitaxel, 1 mg
• J9045 — Injection, carboplatin, 50 mg
• J9046 — Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg
• J9047 — Injection, carfilzomib, 1 mg
• J9048 — Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
• J9049 — Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
• J9050 — Injection, carmustine, 100 mg
• J9051 — Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
• J9052 — Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg
• J9054 — Injection, bortezomib (boruzu), 0.1 mg
• J9055 — Injection, cetuximab, 10 mg
• J9056 — Injection, bendamustine hydrochloride (vivimusta), 1 mg
• J9057 — Injection, copanlisib, 1 mg
• J9060 — Injection, cisplatin, powder or solution, 10 mg
• J9061 — Injection, amivantamab-vmjw, 2 mg
• J9063 — Injection, mirvetuximab soravtansine-gynx, 1 mg
• J9064 — Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg
• J9065 — Injection, cladribine, per 1 mg
• J9071 — Injection, cyclophosphamide (auromedics), 5 mg
• J9072 — Injection, cyclophosphamide (frindovyx), 5 mg
• J9073 — Injection, cyclophosphamide (dr. reddy's), 5 mg
• J9074 — Injection, cyclophosphamide (sandoz), 5 mg
• J9075 — Injection, cyclophosphamide, not otherwise specified, 5 mg
• J9076 — Injection, cyclophosphamide (baxter), 5 mg
• J9098 — Injection, cytarabine liposome, 10 mg
• J9100 — Injection, cytarabine, 100 mg
• J9118 — Injection, calaspargase pegol-mknl, 10 units
• J9119 — Injection, cemiplimab-rwlc, 1 mg
• J9120 — Injection, dactinomycin, 0.5 mg
• J9130 — Dacarbazine, 100 mg
• J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj
• J9145 — Injection, daratumumab, 10 mg
• J9150 — Injection, daunorubicin, 10 mg
• J9151 — Injection, daunorubicin citrate, liposomal formulation, 10 mg
• J9153 — Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
• J9155 — Injection, degarelix, 1 mg
• J9161 — Injection, denileukin diftitox-cxdl, 1 mcg
• J9165 — Injection, diethylstilbestrol diphosphate, 250 mg
• J9171 — Injection, docetaxel, 1 mg
• J9172 — Injection, docetaxel (docivyx), 1 mg
• J9173 — Injection, durvalumab, 10 mg
• J9174 — Injection, docetaxel (beizray), 1 mg
• J9175 — Injection, elliotts' b solution, 1 ml
• J9176 — Injection, elotuzumab, 1 mg
• J9177 — Injection, enfortumab vedotin-ejfv, 0.25 mg
• J9178 — Injection, epirubicin hcl, 2 mg
• J9179 — Injection, eribulin mesylate, 0.1 mg
• J9181 — Injection, etoposide, 10 mg
• J9185 — Injection, fludarabine phosphate, 50 mg
• J9190 — Injection, fluorouracil, 500 mg
• J9196 — Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
• J9198 — Injection, gemcitabine hydrochloride, (infugem), 100 mg
• J9200 — Injection, floxuridine, 500 mg
• J9201 — Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
• J9202 — Goserelin acetate implant, per 3.6 mg
• J9203 — Injection, gemtuzumab ozogamicin, 0.1 mg
• J9204 — Injection, mogamulizumab-kpkc, 1 mg
• J9205 — Injection, irinotecan liposome, 1 mg
• J9206 — Injection, irinotecan, 20 mg
• J9207 — Injection, ixabepilone, 1 mg
• J9208 — Injection, ifosfamide, 1 gram
• J9209 — Injection, mesna, 200 mg
• J9210 — Injection, emapalumab-lzsg, 1 mg
• J9211 — Injection, idarubicin hydrochloride, 5 mg
• J9212 — Injection, interferon alfacon-1, recombinant, 1 microgram
• J9213 — Injection, interferon, alfa-2a, recombinant, 3 million units
• J9214 — Injection, interferon, alfa-2b, recombinant, 1 million units
• J9215 — Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu
• J9216 — Injection, interferon, gamma 1-b, 3 million units
• J9217 — Leuprolide acetate (for depot suspension), 7.5 mg
• J9218 — Leuprolide acetate, per 1 mg
• J9219 — Leuprolide acetate implant, 65 mg
• J9220 — Injection, indigotindisulfonate sodium, 1 mg
• J9223 — Injection, lurbinectedin, 0.1 mg
• J9225 — Histrelin implant (vantas), 50 mg
• J9226 — Histrelin implant (supprelin la), 50 mg
• J9227 — Injection, isatuximab-irfc, 10 mg
• J9228 — Injection, ipilimumab, 1 mg
• J9229 — Injection, inotuzumab ozogamicin, 0.1 mg
• J9230 — Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg
• J9245 — Injection, melphalan hydrochloride, not otherwise specified, 50 mg
• J9246 — Injection, melphalan (evomela), 1 mg
• J9248 — Injection, melphalan (hepzato), 1 mg
• J9249 — Injection, melphalan (apotex), 1 mg
• J9255 — Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg
• J9260 — Injection, methotrexate sodium, 50 mg
• J9261 — Injection, nelarabine, 50 mg
• J9262 — Injection, omacetaxine mepesuccinate, 0.01 mg
• J9263 — Injection, oxaliplatin, 0.5 mg
• J9264 — Injection, paclitaxel protein-bound particles, 1 mg
• J9266 — Injection, pegaspargase, per single dose vial
• J9267 — Injection, paclitaxel, 1 mg
• J9268 — Injection, pentostatin, 10 mg
• J9269 — Injection, tagraxofusp-erzs, 10 micrograms
• J9270 — Injection, plicamycin, 2.5 mg
• J9271 — Injection, pembrolizumab, 1 mg
• J9272 — Injection, dostarlimab-gxly, 10 mg
• J9273 — Injection, tisotumab vedotin-tftv, 1 mg
• J9274 — Injection, tebentafusp-tebn, 1 microgram
• J9275 — Injection, cosibelimab-ipdl, 2 mg
• J9276 — Injection, zanidatamab-hrii, 2 mg
• J9280 — Injection, mitomycin, 5 mg
• J9281 — Mitomycin pyelocalyceal instillation, 1 mg
• J9285 — Injection, olaratumab, 10 mg
• J9286 — Injection, glofitamab-gxbm, 2.5 mg
• J9289 — Injection, nivolumab, 2 mg and hyaluronidase-nvhy
• J9292 — Injection, pemetrexed dipotassium, 10 mg
• J9293 — Injection, mitoxantrone hydrochloride, per 5 mg
• J9294 — Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg
• J9295 — Injection, necitumumab, 1 mg
• J9296 — Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg
• J9297 — Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg
• J9298 — Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
• J9299 — Injection, nivolumab, 1 mg
• J9301 — Injection, obinutuzumab, 10 mg
• J9302 — Injection, ofatumumab, 10 mg
• J9303 — Injection, panitumumab, 10 mg
• J9304 — Injection, pemetrexed (pemfexy), 10 mg
• J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
• J9306 — Injection, pertuzumab, 1 mg
• J9307 — Injection, pralatrexate, 1 mg
• J9308 — Injection, ramucirumab, 5 mg
• J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
• J9311 — Injection, rituximab 10 mg and hyaluronidase
• J9312 — Injection, rituximab, 10 mg
• J9313 — Injection, moxetumomab pasudotox-tdfk, 0.01 mg
• J9314 — Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg
• J9316 — Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
• J9317 — Injection, sacituzumab govitecan-hziy, 2.5 mg
• J9318 — Injection, romidepsin, non-lyophilized, 0.1 mg
• J9319 — Injection, romidepsin, lyophilized, 0.1 mg
• J9320 — Injection, streptozocin, 1 gram
• J9321 — Injection, epcoritamab-bysp, 0.16 mg
• J9322 — Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg
• J9323 — Injection, pemetrexed ditromethamine, 10 mg
• J9324 — Injection, pemetrexed (pemrydi rtu), 10 mg
• J9325 — Injection, talimogene laherparepvec, per 1 million plaque forming units
• J9328 — Injection, temozolomide, 1 mg
• J9329 — Injection, tislelizumab-jsgr, 1mg
• J9330 — Injection, temsirolimus, 1 mg
• J9331 — Injection, sirolimus protein-bound particles, 1 mg
• J9332 — Injection, efgartigimod alfa-fcab, 2mg
• J9333 — Injection, rozanolixizumab-noli, 1 mg
• J9334 — Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
• J9341 — Injection, thiotepa (tepylute), 1 mg
• J9342 — Injection, thiotepa, not otherwise specified, 1 mg
• J9345 — Injection, retifanlimab-dlwr, 1 mg
• J9347 — Injection, tremelimumab-actl, 1 mg
• J9348 — Injection, naxitamab-gqgk, 1 mg
• J9349 — Injection, tafasitamab-cxix, 2 mg
• J9350 — Injection, mosunetuzumab-axgb, 1 mg
• J9351 — Injection, topotecan, 0.1 mg
• J9352 — Injection, trabectedin, 0.1 mg
• J9353 — Injection, margetuximab-cmkb, 5 mg
• J9354 — Injection, ado-trastuzumab emtansine, 1 mg
• J9355 — Injection, trastuzumab, excludes biosimilar, 10 mg
• J9356 — Injection, trastuzumab, 10 mg and hyaluronidase-oysk
• J9357 — Injection, valrubicin, intravesical, 200 mg
• J9358 — Injection, fam-trastuzumab deruxtecan-nxki, 1 mg
• J9359 — Injection, loncastuximab tesirine-lpyl, 0.075 mg
• J9360 — Injection, vinblastine sulfate, 1 mg
• J9361 — Injection, efbemalenograstim alfa-vuxw, 0.5 mg
• J9370 — Vincristine sulfate, 1 mg
• J9376 — Injection, pozelimab-bbfg, 1 mg
• J9380 — Injection, teclistamab-cqyv, 0.5 mg
• J9381 — Injection, teplizumab-mzwv, 5 mcg
• J9382 — Injection, zenocutuzumab-zbco, 1 mg
• J9390 — Injection, vinorelbine tartrate, 10 mg
• J9393 — Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg
• J9394 — Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg
• J9395 — Injection, fulvestrant, 25 mg
• J9400 — Injection, ziv-aflibercept, 1 mg
• J9600 — Injection, porfimer sodium, 75 mg
• J9999 — Not otherwise classified, antineoplastic drugs